BioSpace News Archive

Lonza’s Ibex™ Design planned to take Genmab’s pre-clinical candidates from gene to potential IND within 12 months

Successful completion of the preclinical program has provided strong scientific proof that the GaRP dietary supplement has the potential to be game changing

Magnetic Insight, Inc., the leader in Magnetic Particle Imaging solutions, announced that David Panzarella has been appointed as the company’s Chief Commercial Officer.

Auris Medical Holding Ltd. announced positive interim results from its Phase 1b trial with AM-201 in antipsychotic-induced weight gain and somnolence.

Reata announced late Monday that the second part of its Phase II MOXIe trial met the goal of modified Friedreich’s Ataxia Rating Scale after 48 weeks of treatment.

The UK office of global life sciences logistics company, Biocair, held a Brexit Briefing and Pharma Logistics Workshop in central London on 27 September 2019 for companies and customers with questions about the impending changes to cross-border trade, and how those changes will affect the life sciences sector.

Establishment of a debt financing plan for a maximum amount of 15 million euros, with IPF Partners

The digital-enabled aspect of the manufacturing plant is designed to leverage better use of data to optimize manufacturing processes and increase efficiencies.

The patch is a once-per-day treatment that provides sustained concentrations of Secuado (asenapine), an atypical antipsychotic drug used to treat schizophrenia.

While trials may be listed online in readily accessible databases, it can be hard to know what to search for and how to make sense of the medical jargon of the listings.